1. Cuatrecasas P 1971 Properties of the insulin receptor of isolated fat cell membranes. J Biol Chem 246:7265-74.

2. Cuatrecasas P, Desbuquois B, Krug F 1971 Insulin-receptor interactions in liver cell membranes. Biochem Biophys Res Commun 44:333-9.

3. Megyesi K, Kahn CR, Roth J, Neville DM, Jr., Nissley SP, Humbel RE, Froesch ER 1975 The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. J Biol Chem 250:8990-6.

4. Cuatrecasas P 1972 Affinity chromatography and purification of the insulin receptor of liver cell membranes. Proc Natl Acad Sci U S A 69:1277-81.

5. Fujita-Yamaguchi Y, Choi S, Sakamoto Y, Itakura K 1983 Purification of insulin receptor with full binding activity. J Biol Chem 258:5045-9.

6. Kohanski RA, Lane MD 1985 Homogeneous functional insulin receptor from 3T3-L1 adipocytes. Purification using N alpha B1-(biotinyl-epsilon-aminocaproyl)insulin and avidin-sepharose. J Biol Chem 260:5014-25.

7. Heinrich J, Pilch PF, Czech MP 1980 Purification of the adipocyte insulin receptor by immunoaffinity chromatography. J Biol Chem 255:1732-7.

8. Pilch PF, Czech MP 1979 Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons. J Biol Chem 254:3375-81.

9. Yip CC, Yeung CW, Moule ML 1978 Photoaffinity labeling of insulin receptor of rat adiopocyte plasma membrane. J Biol Chem 253:1743-5.

10. Flier JS, Kahn CR, Roth J, Bar RS 1975 Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63-5.

11. Boni-Schnetzler M, Rubin JB, Pilch PF 1986 Structural requirements for the transmembrane activation of the insulin receptor kinase. J Biol Chem 261:15281-7.

12. Schenker E, Kohanski RA 1991 The native alpha 2 beta 2 tetramer is the only subunit structure of the insulin receptor in intact cells and purified receptor preparations. Arch Biochem Biophys 290:79-85.

13. DeMeyts P, Bainco AR, Roth J 1976 Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem 251:1877-88.

14. Kohanski RA, Lane MD 1983 Binding of insulin to solubilized insulin receptor from human placenta. Evidence for a single class of noninteracting binding sites. J Biol Chem 258:7460-8.

15. Seino S, Bell GI 1989 Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159:312-6.

16. McClain DA 1991 Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-9.

17. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin- like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-88.

18. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-95.

19. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia P, Goldfine ID, Vigneri R, Belfiore A 1999 Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18:2471-9.

20. Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, Conover CA 2002 Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 143:3259-67.

21. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A 2002 A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245-54.

22. Louvi A, Accili D, Efstratiadis A 1997 Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48.

23. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ 1996 Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286-97.

24. Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ 1998 The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 47:269-81.

25. Moller DE, Yokota A, Caro JF, Flier JS 1989 Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3:1263-9.

26. Mosthaf L, Vogt B, Haring HU, Ullrich A 1991 Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci U S A 88:4728-30.

27. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO 2001 Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 7:559-70.

28. Federici M, Porzio O, Lauro D, Borboni P, Giovannone B, Zucaro L, Hribal ML, Sesti G 1998 Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. J Clin Endocrinol Metab 83:2911-5.

29. Valensise H, Liu YY, Federici M, Lauro D, Dell'anna D, Romanini C, Sesti G 1996 Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension. Diabetologia 39:952-60.

30. Spampinato D, Pandini G, Iuppa A, Trischitta V, Vigneri R, Frittitta L 2000 Insulin/insulin-like growth factor I hybrid receptors overexpression is not an early defect in insulin-resistant subjects. J Clin Endocrinol Metab 85:4219-23.

31. Urso B, Cope DL, Kalloo-Hosein HE, Hayward AC, Whitehead JP, O'Rahilly S, Siddle K 1999 Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem 274:30864-73.

32. Dupont J, LeRoith D 2001 Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res 55:22-6.

33. Kim J, Accili D 2002 Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm IGF Res 12:84.

34. Fukuda H, Noguchi T, Iritani N 2001 Transcriptional regulation of insulin receptor gene promoter in rat hepatocytes. Biochem Biophys Res Commun 280:1274-8.

35. Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Foti D 2001 Transcriptional regulation of human insulin receptor gene by the high- mobility group protein HMGI(Y). Faseb J 15:492-500.

36. Knutson VP, Ronnett GV, Lane MD 1982 Control of insulin receptor level in 3T3 cells: effect of insulin- induced down-regulation and dexamethasone-induced up-regulation on rate of receptor inactivation. Proc Natl Acad Sci U S A 79:2822-6.

37. Saad MJ, Folli F, Kahn CR 1995 Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells. Endocrinology 136:1579-88.

38. Kosaki A, Webster NJ 1993 Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J Biol Chem 268:21990-6.

39. Brunetti A, Brunetti L, Foti D, Accili D, Goldfine ID 1996 Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene. J Clin Invest 97:258-62.

40. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL 1996 Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 56:2781-8.

41. Ronnett GV, Knutson VP, Kohanski RA, Simpson TL, Lane MD 1984 Role of glycosylation in the processing of newly translated insulin proreceptor in 3T3-L1 adipocytes. J Biol Chem 259:4566-75.

42. Salzman A, Wan CF, Rubin CS 1984 Biogenesis, transit, and functional properties of the insulin proreceptor and modified insulin receptors in 3T3-L1 adipocytes. Use of monensin to probe proreceptor cleavage and generate altered receptor subunits. Biochemistry 23:6555-65.

43. Olson TS, Bamberger MJ, Lane MD 1988 Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function. J Biol Chem 263:7342-51.

44. Lane MD, Ronnett GV, Kohanski RA, Simpson TL 1985 Posttranslational processing of the insulin proreceptor. Curr Top Cell Regul 27:279-92

45. Lane MD, Slieker LJ, Olson TS, Martensen TM 1987 Post-translational acquisition of ligand binding- and tyrosine kinase- domain function by the epidermal growth factor and insulin receptors. J Recept Res 7:321-54

46. Taylor SI 1992 Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473-90.

47. Williams JF, McClain DA, Dull TJ, Ullrich A, Olefsky JM 1990 Characterization of an insulin receptor mutant lacking the subunit processing site. J Biol Chem 265:8463-9.

48. Sawa T, Imamura T, Haruta T, Sasaoka T, Ishiki M, Takata Y, Takada Y, Morioka H, Ishihara H, Usui I, Kobayashi M 1996 Hsp70 family molecular chaperones and mutant insulin receptor: differential binding specificities of BiP and Hsp70/Hsc70 determines accumulation or degradation of insulin receptor. Biochem Biophys Res Commun 218:449-53.

49. Martin C, Desai KS, Steiner G 1983 Receptor and postreceptor insulin resistance induced by in vivo hyperinsulinemia. Can J Physiol Pharmacol 61:802-7.

50. Dominici FP, Balbis A, Bartke A, Turyn D 1998 Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing growth hormone gene. J Endocrinol 159:15-25.

51. Liu F, Roth RA 1994 Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C alpha mediated phosphorylation sites. FEBS Lett 352:389-92.

52. Liu F, Roth RA 1994 Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites. Biochem J 298:471-7.

53. Kellerer M, Coghlan M, Capp E, Muhlhofer A, Kroder G, Mosthaf L, Galante P, Siddle K, Haring HU 1995 Mechanism of insulin receptor kinase inhibition in non-insulin- dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered. J Clin Invest 96:6-11.

54. Lee J, Pilch PF 1994 The insulin receptor: structure, function, and signaling. Am J Physiol 266:C319-34.

55. Kublaoui B, Lee J, Pilch PF 1995 Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J Biol Chem 270:59-65.

56. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M 1994 Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-73.

57. Terris S, Hofmann C, Steiner DF 1979 Mode of uptake and degradation of 125I-labelled insulin by isolated hepatocytes and H4 hepatoma cells. Can J Biochem 57:459-68.

58. Knutson VP, Ronnett GV, Lane MD 1983 Rapid, reversible internalization of cell surface insulin receptors. Correlation with insulin-induced down-regulation. J Biol Chem 258:12139-42.

59. Desbuquois B, Lopez S, Janicot M, Burlet H, de Galle B, Fouque F 1992 Role of acidic subcellular compartments in the degradation of internalized insulin and in the recycling of the internalized insulin receptor in liver cells: in vivo and in vitro studies. Diabete Metab 18:104-12.

60. Ahmed Z, Smith BJ, Pillay TS 2000 The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett 475:31-4.

61. Sun XJ, Goldberg JL, Qiao LY, Mitchell JJ 1999 Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48:1359-64.

62. Rui L, Fisher TL, Thomas J, White MF 2001 Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276:40362-7.

63. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D 2000 Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition. Mol Cell Biol 20:1489-96.

64. Ronnett GV, Knutson VP, Lane MD 1982 Insulin-induced down-regulation of insulin receptors in 3T3-L1 adipocytes. Altered rate of receptor inactivation. J Biol Chem 257:4285-91.

65. Terris S 1982 Insulin-receptor turnover and down regulation in hepatocytes. Int J Obes 6:125-30.

66. Baura GD, Foster DM, Porte D, Jr., Kahn SE, Bergman RN, Cobelli C, Schwartz MW 1993 Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92:1824-30.

67. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW 2000 Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49:1525-33.

68. Szabo O, Szabo AJ 1972 Evidence for an insulin-sensitive receptor in the central nervous system. Am J Physiol 223:1349-53.

69. Szabo O, Szabo AJ 1975 Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system. Diabetes 24:328-36.

70. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR 1982 Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298:667-9.

71. Kasuga M, Karlsson FA, Kahn CR 1982 Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215:185-7.

72. Kohanski RA 1993 Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. Biochemistry 32:5773-80.

73. Tornqvist HE, Pierce MW, Frackelton AR, Nemenoff RA, Avruch J 1987 Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 262:10212-9.

74. Tornqvist HE, Gunsalus JR, Nemenoff RA, Frackelton AR, Pierce MW, Avruch J 1988 Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells. J Biol Chem 263:350-9.

75. Ablooglu AJ, Kohanski RA 2001 Activation of the insulin receptor's kinase domain changes the rate- determining step of substrate phosphorylation. Biochemistry 40:504-13.

76. White MF, Livingston JN, Backer JM, Lauris V, Dull TJ, Ullrich A, Kahn CR 1988 Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641-9.

77. Kahn CR, White MF, Shoelson SE, Backer JM, Araki E, Cheatham B, Csermely P, Folli F, Goldstein BJ, Huertas P, et al. 1993 The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog Horm Res 48:291-339

78. Kohanski RA, Frost SC, Lane MD 1986 Insulin-dependent phosphorylation of the insulin receptor-protein kinase and activation of glucose transport in 3T3-L1 adipocytes. J Biol Chem 261:12272-81.

79. Whitehead JP, Clark SF, Urso B, James DE 2000 Signalling through the insulin receptor. Curr Opin Cell Biol 12:222-8.

80. Najjar SM, Philippe N, Taylor SI, Accili D 1993 Molecular cloning of pp120/ECTO-ATPase, an endogenous substrate of the insulin receptor kinase. Adv Exp Med Biol 343:169-74

81. Najjar SM, Choice CV, Soni P, Whitman CM, Poy MN 1998 Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J Biol Chem 273:12923-8.

82. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R 2001 Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. Faseb J 15:2099-111.

83. Ren JM, Li PM, Zhang WR, Sweet LJ, Cline G, Shulman GI, Livingston JN, Goldstein BJ 1998 Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47:493-7.

84. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP 1999 Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-8.

85. Strack V, Hennige AM, Krutzfeldt J, Bossenmaier B, Klein HH, Kellerer M, Lammers R, Haring HU 2000 Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta. Diabetologia 43:443-9.

86. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF 2002 Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277:1531-7.

87. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon M, Ye J 2002 Serine phosphorylation of insulin receptor substrate 1 (IRS-1) by inhibitor KappaB kinase (IKK) complex. J Biol Chem 25:25

88. Lewis RE, Cao L, Perregaux D, Czech MP 1990 Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry 29:1807-13.

89. Dunaif A, Xia J, Book CB, Schenker E, Tang Z 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96:801-10.

90. Storgaard H, Song XM, Jensen CB, Madsbad S, Bjornholm M, Vaag A, Zierath JR 2001 Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected]. Diabetes 50:2770-8.

91. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM 2002 Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87:226-34.

92. Qiao LY, Zhande R, Jetton TL, Zhou G, Sun XJ 2002 In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J Biol Chem 277:26530-9.

93. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI 2001 Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437-46.

94. Petersen KF, Shulman GI 2002 Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90:11G-18G.

95. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-8.

96. Skolnik EY, Marcusohn J 1996 Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev 7:161-73.

97. Ravichandran LV, Esposito DL, Chen J, Quon MJ 2001 Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 276:3543-9.

98. Matsumoto M, Ogawa W, Teshigawara K, Inoue H, Miyake K, Sakaue H, Kasuga M 2002 Role of the insulin receptor substrate 1 and phosphatidylinositol 3- kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51:1672-80.

99. Greene MW, Garofalo RS 2002 Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 41:7082-91.

100. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, et al. 1995 Membrane glycoprotein PC-1 and insulin resistance in non-insulin- dependent diabetes mellitus. Nature 373:448-51.

101. Maddux BA, Goldfine ID 2000 Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 49:13-9.

102. Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, Frittitta L 2001 The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 50:831-6.

103. Stefan C, Wera S, Stalmans W, Bollen M 1996 The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes 45:980-3.

104. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA 1995 Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 270:22085-8.

105. Rasmussen SK, Urhammer SA, Pizzuti A, Echwald SM, Ekstrom CT, Hansen L, Hansen T, Borch-Johnsen K, Frittitta L, Trischitta V, Pedersen O 2000 The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes 49:1608-11.

106. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW 2002 alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 277:19991-7.

107. Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J 2002 Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. Int J Oncol 21:965-71.

108. Mathews ST, Srinivas PR, Leon MA, Grunberger G 1997 Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci 61:1583-92

109. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G 2000 Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164:87-98.

110. Jahnen-Dechent W, Schinke T, Trindl A, Muller-Esterl W, Sablitzky F, Kaiser S, Blessing M 1997 Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496-503.

111. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G 2002 Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51:2450-8.

112. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, et al. 1985 Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-61.

113. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, et al. 1985 The human insulin receptor cDNA: the structural basis for hormone- activated transmembrane signalling. Cell 40:747-58.

114. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et al. 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. Embo J 5:2503-12.

115. Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ 1987 Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301-7.

116. MacDonald RG, Pfeffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A 1988 A single receptor binds both insulin-like growth factor II and mannose- 6-phosphate. Science 239:1134-7.

117. Accili D, Cama A, Barbetti F, Kadowaki H, Kadowaki T, Taylor SI 1992 Insulin resistance due to mutations of the insulin receptor gene: an overview. J Endocrinol Invest 15:857-64.

118. Ebina Y, Araki E, Taira M, Shimada F, Mori M, Craik CS, Siddle K, Pierce SB, Roth RA, Rutter WJ 1987 Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A 84:704-8.

119. O'Neill TJ, Zhu Y, Gustafson TA 1997 Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation. J Biol Chem 272:10035-40.

120. Chen J, Sadowski HB, Kohanski RA, Wang LH 1997 Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci U S A 94:2295-300.

121. Laviola L, Giorgino F, Chow JC, Baquero JA, Hansen H, Ooi J, Zhu J, Riedel H, Smith RJ 1997 The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. J Clin Invest 99:830-7.

122. Moodie SA, Alleman-Sposeto J, Gustafson TA 1999 Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem 274:11186-93.

123. Dey BR, Furlanetto RW, Nissley P 2000 Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun 278:38-43.

124. Kasus-Jacobi A, Bereziat V, Perdereau D, Girard J, Burnol AF 2000 Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene 19:2052-9.

125. Ligensa T, Krauss S, Demuth D, Schumacher R, Camonis J, Jaques G, Weidner KM 2001 A PDZ domain protein interacts with the C-terminal tail of the insulin- like growth factor-1 receptor but not with the insulin receptor. J Biol Chem 276:33419-27.

126. Hubbard SR, Wei L, Ellis L, Hendrickson WA 1994 Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-54.

127. Hubbard SR 1997 Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. Embo J 16:5572-81.

128. Garrett TP, McKern NM, Lou M, Frenkel MJ, Bentley JD, Lovrecz GO, Elleman TC, Cosgrove LJ, Ward CW 1998 Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394:395-9.

129. Williams PF, Mynarcik DC, Yu GQ, Whittaker J 1995 Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis. J Biol Chem 270:3012-6.

130. Mynarcik DC, Yu GQ, Whittaker J 1996 Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit. J Biol Chem 271:2439-42.

131. Whittaker J, Groth AV, Mynarcik DC, Pluzek L, Gadsboll VL, Whittaker LJ 2001 Alanine Scanning Mutagenesis of a Type 1 Insulin-like Growth Factor Receptor Ligand Binding Site. J Biol Chem 276:43980-6.

132. Kristensen C, Wiberg FC, Andersen AS 1999 Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors. Role of C-terminal of receptor alpha subunit. J Biol Chem 274:37351-6.

133. Christiansen K, Tranum-Jensen J, Carlsen J, Vinten J 1991 A model for the quaternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl Acad Sci U S A 88:249-52.

134. Tulloch PA, Lawrence LJ, McKern NM, Robinson CP, Bentley JD, Cosgrove L, Ivancic N, Lovrecz GO, Siddle K, Ward CW 1999 Single-molecule imaging of human insulin receptor ectodomain and its Fab complexes. J Struct Biol 125:11-8.

135. Woldin CN, Hing FS, Lee J, Pilch PF, Shipley GG 1999 Structural studies of the detergent-solubilized and vesicle- reconstituted insulin receptor. J Biol Chem 274:34981-92.

136. Luo RZ, Beniac DR, Fernandes A, Yip CC, Ottensmeyer FP 1999 Quaternary structure of the insulin-insulin receptor complex. Science 285:1077-80.

137. Ottensmeyer FP, Beniac DR, Luo RZ, Yip CC 2000 Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry 39:12103-12.

138. Baura GD, Foster DM, Kaiyala K, Porte D, Jr., Kahn SE, Schwartz MW 1996 Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45:86-90.

139. Zhao W, Alkon DL 2001 Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177:125-34.

140. Garofalo RS 2002 Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol Metab 13:156-62.

141. Hribal ML, Oriente F, Accili D 2002 Mouse models of insulin resistance. Am J Physiol Endocrinol Metab 282:E977-81.

142. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H 1996 Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-9.

143. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22:818-35.

144. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR 1997 Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-72.

145. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D 2000 Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105:199-205.

146. Kato H, Faria TN, Stannard B, Roberts CT, Jr., LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin- like growth factor-I (IGF-I) receptor. Characterization of kinase- deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem 268:2655-61.

147. Kahn CR, Bruning JC, Michael MD, Kulkarni RN 2000 Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus. J Pediatr Endocrinol Metab 13:1377-84.

148. Mauvais-Jarvis F, Kahn CR 2000 Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice? Diabetes Metab 26:433-48.

149. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR 1998 A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-69.

150. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Kahn CR, Shulman GI 2000 Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105:1791-7.

151. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED 2002 Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-39.

152. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR 2002 Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25-38.

153. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, Benito M 2001 Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108:1205-13.

154. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97.

155. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-39.

156. Mauvais-Jarvis F, Virkamaki A, Michael MD, Winnay JN, Zisman A, Kulkarni RN, Kahn CR 2000 A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes 49:2126-34.

157. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR 2000 Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-5.

158. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, Hafen E 2001 An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr Biol 11:213-21.

159. Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, Buchman AR, Ferguson KC, Heller J, Platt DM, Pasquinelli AA, Liu LX, Doberstein SK, Ruvkun G 2001 Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 15:672-86.

160. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G 1997 daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942-6.

161. Wolkow CA, Kimura KD, Lee MS, Ruvkun G 2000 Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290:147-50.

162. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS 2001 A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292:107-10.

163. Rulifson EJ, Kim SK, Nusse R 2002 Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 296:1118-20.

164. Yamazaki H, Nusse R 2002 Identification of DCAP, a drosophila homolog of a glucose transport regulatory complex. Mech Dev 119:115.